• Company announced discovery of high-grade silver mineralization at Grauer Wolf target
• Excellon continues to develop and test new targets along the 36-kilometer strike length
• EXN advancing a precious metals growth pipeline in Idaho, Mexico and Germany

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2), a silver and base metals producer with operations in Mexico and precious metal exploration projects in Mexico, Idaho and Germany, has announced a new discovery. The discovery of high-grade silver mineralization comes at Grauer Wolf, the fourth target drilled at EXN’s Silver City project (https://ibn.fm/1vKtG). According to the announcement, the discovery is located on a geological site with little historical mining and adds a fourth priority area for follow-up in the 2021 drilling program at Silver City. With eight holes still outstanding, there is strong potential for additional discoveries in parallel strikes. The company is in the process of planning and preparing for more extensive drilling for its Bräunsdorf, Reichenbach, Peter Vein and now Grauer Wolf projects. Excellon is focused on advancing a precious metals growth pipeline through exploration and development of projects that include:

• Platosa — 11,000 hectares hosting the highest-grade silver mine in Mexico and 100% owned by EXN (https://ibn.fm/vCZjs)
• Kilgore — 6,788 hectare high-quality gold development project in Idaho and 100% owned by EXN (https://ibn.fm/StydP)
• Silver City — high-grade epithermal silver district in Saxony, Germany with the option to own 100% (https://ibn.fm/N8Jm9)

The 16,400-hectare Silver City project has been mined for 750 years. Records indicate high-grade silver production in excess of 1,000 g/t was mined throughout the area. Mining slowed to a standstill in the late-19th century after Germany dropped the silver standard in 1873 and the gold/silver ratio skyrocketed when silver prices plummeted. EXN is the first modern-day exploration program to focus on precious metals throughout the area, and the company is already seeing promising results. Thanks to this new discovery, Grauer Wolf is now the fourth priority area for follow-up in the Silver City 2021 drilling program. Lesser known and located 1.5 kilometers north of the Reichenbach target, Grauer Wolf is a relatively unexploited mafiac volcanic contact. EXN continues to develop and test new targets along the Silver City Project, a 36-kilometer strike length on the Bräunsdorf license that historical records indicate has produced at least 882 tonnes of silver as well as zinc and lead (https://ibn.fm/dfDzR). Many of the vein systems under this license have only been mined at shallow depths leaving the potential for many new discoveries. Excellon’s vision is to create wealth by realizing strategic opportunities through discipline and innovation for the benefit of its employees, communities and shareholders. The company also aims to continue capitalizing on current market conditions by acquiring undervalued projects. For more information, visit the company’s website at www.ExcellonResources.com. NOTE TO INVESTORS: The latest news and updates relating to EXN are available in the company’s newsroom at https://ibn.fm/EXN

• UEC president CEO Amir Adnani is featured on a recent episode of Bell2Bell Podcast.
• Adnani notes that Uranium Energy Corp. is focused on rebuilding, restarting a domestic infrastructure to mine uranium for carbon-free nuclear energy.
• The Company’s production area in the Burke Hollow project is the newest, largest ISR well field being developed in the country.

Uranium Energy (NYSE American: UEC) president and CEO Amir Adnani was featured on a recent episode of The Bell2Bell Podcast (https://ibn.fm/6mYtD), a podcast series focused on providing informative updates and exclusive interviews with executives leading companies that are operating in fast-moving industries. Under Adnani’s guidance, Uranium Energy advanced from concept to U.S. production in its first five years of operation; UEC currently has an extensive pipeline of low-cost, near-term production projects.

“Uranium Energy Corp. is a U.S.-focused developer of uranium projects using the low-cost and environmentally friendly in-situ recovery (‘ISR’) method,” said Adnani during the podcast as he provided an overview of the company’s business model. “In South Texas, we have our hub and spoke strategy. This is anchored by our fully licensed Hobson Processing Facility, one of only a few uranium processing plants in the country. We have a number of projects . . . which will be a source of U.S.-mined uranium.”

In addition to discussing the company’s business model, Adnani touched on recent company news, specifically talking about the company’s plans moving forward as the United States looks to decrease its reliance on carbon-based fuels. “Uranium is used for generating electricity in nuclear power plants, and 55% of U.S. carbon-free energy comes from nuclear power,” he said, noting that almost all of the uranium currently needed in the country to fuel reactors is coming from foreign sources.

“We have completely lost the ability to mine uranium in the U.S. from domestic sources,” he continued. “You and I both know the importance of local sources of vital needs, be it energy sources, be it masks, be it pharmaceuticals. So what we’re trying to do is to really rebuild and restart the domestic foundation to mine uranium — the fuel that is needed to run our 94 reactors in this country.”

During the interview, Adnani talked about the federal government’s bipartisan support of a U.S. Uranium Reserve and the allocation of funds to purchase uranium produced by U.S. mines, noting that he’d never seen such a move in his extensive experience in the industry. “[UEC] is getting ready to supply uranium to the global market and this new U.S. reserve,” he noted, pointing to the company’s Burke Hollow project, located in Texas. Burke Hollow’s initial production area is the newest and largest ISR well field being developed in the country (https://ibn.fm/6Br4k).

“We need to have a foundation to mine uranium domestically in the United States,” Adnani stated. “We’re rising to that occasion as a company. As a company we are today, at our Burke Hollow project… currently building one of the largest production areas currently in the United States…We have rigs on the property, we’ve got local staff, our team. We’re hiring locally. We’re creating jobs and adding to the economic development of the local communities that we’re in, in Texas…These are incredible opportunities, because not only are we creating local jobs…we’re also tying it back to developing the ability to mine uranium domestically. And again, this dovetails strategically with our plans to be a key supplier to the U.S Uranium Reserve.”

Adnani also talked about the strength of the company’s portfolio, which includes projects in Texas, Wyoming, New Mexico, Colorado and Arizona, as well as Canada and Paraguay, noting that the company looks to be ideally positioned as the market looks to expand and grow.

Uranium Energy Corp. is a U.S.-based uranium mining and exploration company that controls one of the country’s largest historical uranium exploration and development databases. Founded in 2003, UEC is headquartered in Corpus Christi, Texas.

For more information, visit the company’s website at www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

• Studies confirm natural active ingredient, which is in MustGrow’s biopesticide, has a positive impact on soil health
• Soil micro-organisms play crucial role in soil fertility, plant health
• MustGrow’s safe, effective natural biopesticide is plant based, derived from the mustard seed’s natural defense mechanism

MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has released study findings that confirm that the active ingredient in its mustard plant-based technology actually has a positive impact on soil health (https://ibn.fm/uLwuc). The studies have found that an application of the natural ingredient Allyl Isothiocyanate (“AITC”) returns organic plant material to the soil and contributes to the environmental and ecological security of the plant-based food supply as well as the planet generally.

“The active ingredient, AITC, in MustGrow’s mustard plant-based technology is perfect for use in modern, more sustainable pest control strategies,” said MustGrow scientific advisor Dr. Matthew J. Morra. “A biopesticide that is effective, dissipates quickly, leaves no harmful residues, and once gone, improves the soil ecosystem.” A professor emeritus of soil biochemistry at the University of Idaho, Morra is a leading world expert on products derived from oilseeds; he also has impressive expertise in developing mustard-based biopesticides.

Highlights from the study, which was separate from MustGrow, indicate that an application of AITC returns organic plant material to the soil, improves the environmental and ecological security of the planet, and creates a healthy microbial ecological environment for soil, which increases beneficial bacteria. In addition, AITC dissipates from the soil quickly, thereby eliminating any potential long-term toxicity to microorganisms.

The potential impact of MustGrow’s biopesticide on the soil cannot be overlooked. Soil micro-organisms play a crucial role in soil fertility and plant health. The use of synthetic chemicals in soil fumigation has been proven to harm beneficial micro-organisms, fungi and bacteria in the soil, actually creating a negative impact on soil fertility, plant health and nutrient transformation. So the now-verified positive impact that AITC has on soil is significant. Studies and research done on AITC have consistently concluded that the ingredient has a positive effect on the environmental and ecological security of the planet.

MustGrow’s remarkably safe and effective natural biopesticide is plant based, derived from the mustard seed’s natural defense mechanism to control diseases, pests and weeds with an organic food-grade biopesticide. The product is applied to the soil before seeds are planted. There is a growing interest in safe, effective, and plant-based biopesticides as farmers, consumers and investors alike become more aware of and committed to natural alternatives to synthetic chemical pesticides.

An agriculture biotech company, MustGrow is focused on providing natural, science-based biological solutions for high-value crops such as fruits and vegetables. The company is ideally positioned to leverage the growing momentum favoring alternatives to synthetic chemicals. As global agriculture looks to move closer to sustainable ways of boosting yields and crop protection, MustGrow continues to position itself as an essential part of the food landscape of the future with its mustard plant-based biopesticide.

For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF

• Pure Extracts is preparing to deliver shipment of 85% pure CBD distillate
• Company proud of quality offering produced in world-class facility
• PULL uses proprietary state-of-the art, sub-critical/super-critical CO₂extraction system

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company, has signed a contract for its first CBD oil commercial sale on the wholesale market (https://ibn.fm/92kPG). Pure Extracts is preparing to deliver the first of what it anticipates will be multiple shipments this year of its 85% pure CBD distillate under this contract. “We are excited to have completed our first commercial order, and we are proud of the quality of distillate that our extraction team has produced in our new, world-class facility,” said Pure Extracts CEO Ben Nikolaevsky. According to a recent update, Pure Extracts finished construction of its state-of-the-art facility last year (https://ibn.fm/B65HW). Located about 20 minutes north of Whistler, British Columbia, the center is built to European Union GMP standards and is the perfect complement to Pure Extracts’ Standard Processing License, which the company received from Health Canada on September 25, 2020 through its wholly owned subsidiary, Pure Extracts Manufacturing Corp. Pure Extracts is gaining a reputation for providing exceptionally pure THC and CBD full spectrum oil (“FSO”) and distillate. The company obtains such a high-quality offering by using its proprietary state-of-the art, sub-critical/super-critical CO₂ extraction system. The distillate is ideally suited for use in most cannabis 2.0 products, including beverages, edibles and vape pens. With such a high-quality product available, it is perhaps no surprise that the company is seeing success in the toll processing and white labeling space. Pure Extract offers the ideal solutions for LPs that lack the extraction expertise and requisite equipment to manufacture their own raw materials. In addition, Pure Extracts is also developing its own private label of products; the Pure Pulls and Pure Chews brand, which will include vape pens and edibles, will incorporate the company’s own full spectrum THC and CBD-based extracted oils. In conjunction with the company’s commitment to strengthen its brand awareness and expand into new spaces, Pure Extracts is teaming up with Native Ads Inc. and Winning Media to create and execute digital advertising campaigns. Under the terms of the agreement, Native Ads and Winning Media will provide strategic digital media services, marketing coordination, content production and data analytics services — all designed to support Pure Extracts as it moves forward with its strategic growth and expansion plans. Pure Extracts Technologies Inc., headquartered in Pemberton, British Columbia, is a plant-based extraction company with a new vertical in functional mushrooms with plans the enter burgeoning psychedelic mushroom sector once it receives a Dealer’s Licence from Health Canada. A Dealer’s Licence would allow the company to handle, manufacture and sell substances such as psilocybin and psilocin. The company is positioned to be the dominant extraction company and a leader in the rapid development and commercialization of functional and medicinal psychedelic products. For more information, visit the company’s website at www.PureExtractsCorp.com. NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

• UME is trusted supplier of FDA-approved antibody, antigen test kits
• United moved quickly to address growing needs created by COVID-19
• Company dedicated to providing guidance to aging population, their families and medical staff supporting them

United Medical Equipment Business Solutions Network is a company focused on the needs of aging patients and veteran communities as well as those impacted by the COVID-19 pandemic. United is a trusted supplier of FDA-approved antibody and antigen test kits, medical equipment and personal protective equipment (“PPE”). As the world attempts to control this pandemic, it is essential to quickly identify who is infected and who has already been infected. Antibody testing determines whether or not a patient has had COVID-19 in the past while antigen testing determines whether or not a patient currently has COVID-19.

An antibody test can help determine how many people have had and recovered from COVID-19. This includes those that were asymptomatic. Since individuals are presenting various symptoms, ranging from no symptoms to full respiratory failure, symptoms alone cannot accurately confirm if someone has been infected. Antibody tests have limited use in detection but help to determine accurate case numbers and research into immunity.

The antigen rapid test allows for quick diagnosis that can help curb the spread of the virus. Antigens are a specific protein that sits on the surface of the virus. These rapid tests identify antigens when the individual is contagious. That individual can then be placed into quarantine, stopping the spread of the virus (https://ibn.fm/xB6J7).

The FDA-approved CareStart(TM) COVID-19 Antigen Rapid POC test is part of United’s answer in combating the spread of the virus. The test is administered by medical professionals to detect COVID-19 antigens. This test identifies acute infection with 88.4% sensitivity and 100% specificity, and helps provide critical answers about active infections to patients and healthcare workers alike (https://ibn.fm/Q8js4).

United moved quickly to address the growing needs created by the COVID-19 pandemic. In addition to providing test kits, COVID-19 supplies and products (https://ibn.fm/KgD8i), and PPE equipment with flexible payment options, the company has acted as a trusted senior referral source for independent living, assisted living, hospice, memory care, skilled nursing and senior care centers.

Throughout 2020 and into 2021, the elderly have been particularly vulnerable to this pandemic. United is dedicated to providing guidance for the aging population, their families, and the medical community that serves them.

For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed

• TAAT(TM) partnered with CROSSMARK based on powerful formula for creating, implementing and executing strategies for CPG merchandising
• Of particular interest is CROSSMARK’S success in commercializing tobacco alternatives that achieved dominant e-cigarette market share
• TAAT committed to growing innovative tobacco-free, nicotine-free alternative to traditional cigarettes

TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF), a life science company dedicated to giving legal-aged smokers a nicotine- and tobacco-free smoking experience, recently unveiled TAAT(TM), its flagship product — and the product has been greeted with an exceptional response. Representative of the interest shown in the product — and the promising future of the innovative smoking alternative — is the agreement TAAT recently signed with CROSSMARK, an omnichannel CPG sales agency. “Ever since TAAT was first placed on store shelves in Ohio in December 2020, we have received glowing feedback about the product from both legal-aged smokers and retailers alike,” said TAAT CEO Setti Coscarella. “It is common knowledge in the world of business that this is only the first step towards the success of a product launch. We selected CROSSMARK to represent TAAT because their formula for creating, implementing and executing strategies for CPG merchandising has been honed over decades of bringing new consumer products to mainstream retail channels.” Through CROSSMARK, all three TAAT varieties — Original, Smooth and Menthol —may be available at more than 100,000 convenience stores located throughout the country. CROSSMARK, a sales and merchandising agency for CPG products, has established relationships with major retailers across all channels. Of particular interest to TAAT is CROSSMARK’S success in commercializing tobacco alternatives that achieved dominant e-cigarette market share in the United States. “At CROSSMARK, we pride ourselves in our familiarity with what intrigues today’s consumers and what consistently delivers value to them,” said Jeff Neihart. CROSSMARK vice president and general manager of customer service. “We are very selective in onboarding only a limited number of new brands each year, and it gives me great satisfaction to have found a match in TAAT as a novel, relevant, and ‘sticky’ product that could continue to resonate well with legal-aged smokers. “Furthermore, we are confident that with the combination of our presence in the retail channels through which tobacco products are sold and our experience in executing strategies within the category of tobacco alternatives, we can amplify the value proposition offered by TAAT to legal-aged smokers in the United States and help the company meet or exceed their goals,” Neihart continued. “CROSSMARK has been in the business of connecting retailers with a curated range of CPG products for more than 100 years, and we are excited to introduce TAAT to tobacco retailers who we predict will find the product appealing and will want to carry it in their respective stores.” According to the agreement, in addition to introducing TAAT to potential wholesale and retail locations, CROSSMARK will provide an in-field execution team focused on supporting in-store acceptance, merchandising and reorders of TAAT products. The company will also provide TAAT with extensive promotional, trade marketing and analytics support as the two companies partner together to make the most of existing initiatives and evaluate the possibilities for national growth and expansion. “In addition to leveraging their relationships with major retailers and wholesalers across our targeted channels for TAAT, CROSSMARK also offers an impressive suite of ‘back office’ functions including marketing, data analytics, and order processing support,” said Coscarella. “Altogether, these services could enable TAAT to penetrate the tobacco market much more rapidly and efficiently compared to building out our own national sales and merchandising team from scratch. One only has to look at the results CROSSMARK achieved in commercializing another tobacco brand across the United States to know that they have both the experience and know-how to launch a product to an audience of legal-aged smokers, which could assist the company in realizing its objectives for the TAAT product launch. We are thrilled to have CROSSMARK on our side as we seek to make TAAT products available to legal-aged smokers throughout the United States.” TAAT has developed TAAT, a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco, a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched in the United States in Q4 2020 and is focused on positioning itself in the $814 billion global tobacco industry. For more information, visit the company’s website at www.TAATGlobal.com. NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

• Industry experts expect rare earth elements (“REE”) space to continue to grow significantly through 2030
• UUUU entered REE business last year to complement its core uranium production; plans commercial production of intermediate REE product in H1 2021
• Company expects to become leading U.S. player in this field, supplying up to 50% of nation’s rare earth demand in next few years

The rare earth elements (“REE”) market continues to be of interest for investors and governments around the world amid the heightened uncertainty due to trade restrictions out of China and increased demand for REE magnets, according to an article published by “Investing News Network” (https://ibn.fm/HfbHa). The sector provides the critical metals required for clean energy technologies and electronics that penetrates many segments of both the consumer and business spaces. As the country’s largest uranium producer and the leading critical minerals producer, Energy Fuels (NYSE American: UUUU) (TSX: EFR) has entered the REE space, committed to domestically supplying another critical mineral needed to making the new Biden Administration’s clean energy goals a reality.

After the initial hit to prices in the first half of 2020 as lockdowns and containment measures in China impacted the global supply chains, the REE space rebounded strongly in the second half of the year. And it appears that the sector’s growth will not stop there.

REEs, used in many tech devices and clean energy technologies such as smartphones, wind turbines and electric vehicles, will be critical for the sector over the next decade. Although REE’s supply and demand dynamics are still uncertain due to the pandemic, most analysts are optimistic for 2021 and beyond.

The push for the sector comes as Western countries continue to create supply chains less dependent on China. The article cites David Merriman of Roskill, a commodity research firm, who expects electric and hybrid vehicles’ drivetrains and wind turbine — which all use rare earth permanent magnets — to drive the sector’s robust growth for the remainder of the decade. For example, it is expected that REE demand for automotive applications will grow around 26.5% year-on-year in 2021.

Adamas Intelligence, a research firm focused on strategic metals and minerals, also expects demand to bounce back for nearly all end-use categories for rare earth elements in 2021. Global passenger battery EV, plug-in hybrid EV and hybrid EV sales are expected to drive the growth, increasing collectively by 20 to 40% year over year.

In April 2020, UUUU set out to penetrate the REE market as a complement to its core uranium product lines. Since the announcement of the expansion into REE business, the company has made significant strides, quickly becoming an emerging player in the space. Its initial goal is to enter the commercial REE business in H1 2021 and to supply up to 50% of U.S. rare earth demand contained in a mixed REE concentrate over the next few years.

The company also has plans to install REE separation, and perhaps additional downstream capabilities, over the next few years. The ambitious plans are to be achieved with the company’s existing infrastructure (https://ibn.fm/XhQAQ). With its expansion into the growing REE market and all debt paid off last year, the company is leveraging a robust business model that allows it to be well positioned to capitalize on the increasing momentum for the REE space.

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

• PlantX to display and sell its indoor plants at Farm Cup Coffee’s highly attractive West Hollywood location
• The careful partnership aligns perfectly with PlantX’s commitment to supporting healthy lifestyles and community empowerment
• PlantX opens wide the potential of indoor plants, making it both easy and appealing to discover what the world of plants can provide

As the digital face of the plant-based community, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is taking another step to solidify its position as a one-stop shop for everything plant-based. The Company recently announced that has entered into a new collaboration with Farm Cup Coffee, an innovative coffee shop that offers organic coffee that is ethically sourced from farm owners around the world. PlantX will display and sell its houseplants at Farm Cup Coffee’s new physical location in West Hollywood, California (https://ibn.fm/TADOE).

“Displaying our indoor plants in the highly attractive Farm Cup Coffee store in West Hollywood will expand PlantX’s reach to its customers and boost our brand visibility,” said PlantX founder Sean Dollinger. “We are thrilled to collaborate with the Farm Cup Coffee team, whose passion for sustainability is echoed by PlantX’s aim to inspire people to adopt healthier, more eco-friendly lifestyles.”

PlantX anticipated that the collaboration will heighten its presence in one of L.A.’s most sought-after retail locations. The company will be displaying a wide range of indoor plants, from succulents to an exotic variety of potted flora. The carefully thought-out partnership aligns perfectly with PlantX’s commitment to supporting healthy lifestyles and community empowerment.

Indoor plants are only a fresh and beautiful introduction to what PlantX offers. The Company’s mission is to raise plant awareness in a hyper-palatable world to simplify plant-based living. PlantX lives its mission by striving to deliver the highest-quality products with the best service available.

And the PlantX product offering is widespread. From its line of indoor plants, which are now on display at Farm Cup Coffee, to its groceries, meal deliveries and plant-based gifts, the Company opens wide the potential of plants, making it both easy and appealing to discover what the world of plants can provide.

Partnering with Farm Cup Coffee in this endeavor was a no-brainer. The brand, which began in a Citroen van outfitted as a mobile and stylish coffee shop, focuses on positivity and is committed to sustainability. “We not only want you to drink good coffee, we want you to feel good drinking it too,” said Farm Cup Coffee co-founder Tony Yuan. “This harmonious partnership with PlantX at our West Hollywood location will help promote a happy and sustainable lifestyle for the local community.

With its fast-growing category verticals, PlantX offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans to expand its product lines to include cosmetics, clothing and its own water brand. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, provide education.

To learn more about this company, visit www.PlantX.com, www.PlantX.ca and www.Investor.Plantx.com and view the PlantX for Plant-Based Investors.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• POAI subsidiary inks contract with significant pharmaceutical company
• TumorGenesis announces sale of media to research medical centers in New York City, Boston
• Potential market for 3D cancer cell culture media expected to reach $3.2 billion sales worldwide by 2027

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that one of its wholly owned subsidiaries, Soluble Biotech, recently inked another contract with a large pharmaceutical company (https://ibn.fm/OpaJb). POAI also announced that TumorGenesis, one of its wholly owned subsidiaries, has sold media to two top research medical centers (https://ibn.fm/uXorQ).

Soluble Biotech’s contract will involve using the company’s proprietary protein formulation technology to improve the solubility and stability of a protein therapeutic destined for future clinical use.

“This opportunity may also lead to a long-term relationship whereby Soluble Biotech develops a strategic partnership to support several other therapeutics currently under development within the pharmaceutical company,” said Soluble Biotech Founder and President Dr. Larry DeLucas.

In additional company news, Predictive Oncology shared details about the sale of media to two top research medical centers. The sales by TumorGenesis, POAI’s wholly owned subsidiary, were repeat orders from hospitals in New York City and Boston, and included culturing ovarian cancer cells with specific research goals.

“We believe that this is the future of ovarian cancer research, which creates new possibilities to coming up with new treatments for this chronic and deadly disease,” said Predictive Oncology President and CEO Dr. Carl Schwartz. “In order for us to find better drugs, we have to be able to grow the right patient cells in the right media. Building the ‘living library’ of cancer cells for drug screening and discovery is the right first step.” POAI is committed to this first step and is the process of building the largest existing database of drug response data in the world.

The announcement noted that TumorGenesis can replicate ovarian cancer cells in a laboratory—outside of the patient’s body. The company has 15 ovarian cancer cell lines along with the media to grow those cells.

“These tissues, in the right TumorGenesis media, replicate not only the DNA/RNA and proteomic signatures but also replicate the histological structures that can be seen in staining, outside the patient’s body,” said TumorGenesis President and board member Richard Gabriel. The process produces invaluable information that can be used by oncologists and other cancer treatment experts to potentially identify and prescribe treatments and care for cancer patients, resulting in more positive outcomes.

The potential market for what POAI does — 3D cancer cell culture media — is expected to reach $3.2 billion sales worldwide by 2027. The space is so explosive because it currently offers the best available models for cancer drug discovery and development.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a road map to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of more than 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• Gage Cannabis recently closed on Regulation A equity financing offering, raising gross proceeds of $50 million
• Issuance was oversubscribed, resulted in addition of over 1,000 new investors to Gage Cannabis’ shareholder base
• Gage Cannabis plans to use the proceeds to further expand Gage’s retail reach, pursue M&A opportunities and help solidify the company’s position as one of the leading operators in the state of Michigan
• Company also announced appointment of Richard Mavrinac to Board of Directors

Gage Growth Corp. (d.b.a. Gage Cannabis) (“Gage Cannabis”), a leading vertically integrated cannabis operator currently focused exclusively on the Michigan market, recently announced that it had successfully concluded its Regulation A, Tier 2, equity financing offering. The equity issuance consisted of Gage Cannabis issuing 28,571,400 subordinate voting shares for total gross proceeds of $50 million, the maximum amount qualified under the company’s offering circular. The offering was oversubscribed by both institutional and retail investors and has led to a significant expansion of the company’s shareholder base through the addition of over 1,000 new investors (https://ibn.fm/gPEro). “We are humbled and excited by the significant interest and investor demand we received for our oversubscribed Reg A financing,” said Gage Cannabis President Fabian Monaco. “Michigan is one of the fastest growing cannabis markets in the United States, and Gage is well positioned with a robust balance sheet to continue to grow our market share as the leading operator with the best brands in the state. This is a great first step in our journey to becoming a publicly traded company, and we’re excited to continue to drive long-term shareholder value.” Gage Cannabis has been one of the prime beneficiaries from Michigan’s move to legalize the use of recreational marijuana in December 2019. Since then, Gage Cannabis has pursued an aggressive expansion plan, which has seen the company open 6 medical or adult-use locations across the state, with a further 10+ locations slated to open in 2021. The company’s rapidly expanding footprint has been largely predicated on the strong underlying sales growth witnessed within the sector. Cannabis retailers sold approximately $450 million worth of recreational marijuana products in the state of Michigan over the twelve months following the legalization decision on December 1, 2019, an achievement which was significantly boosted by the Michigan State Government’s decision to nominate the cannabis industry as an ‘essential sector’ during the COVID-19 outbreak (https://ibn.fm/YsVHi). Remarkably, the sector’s sales have continued to thrive, rising to a run-rate of over $13 million a week in recent months (https://ibn.fm/umNmb). Should that rate be maintained, sales growth for the sector could rise by nearly 400 percent year-over-year to approximately $1.6 billion over the course of the next year. “It really is just explosive growth in Michigan,” stated Sloane Barbour, the chief revenue officer of cannabis industry recruitment agency FlowerHire (https://ibn.fm/nBNua). Gage Cannabis plans to use the proceeds from its recently closed Regulation A equity financing to further cement a dominant position within the Michigan state marijuana industry by expanding its retail footprint and pursuing accretive acquisitions which could assist in further expanding their market share. The company has also stated its intent to pursue a potential go-public transaction, which it expects to complete in the first quarter of 2021. In addition to the equity issuance, Gage Cannabis also seized on the opportunity to update investors on a recent addition to the company’s Board of Directors. Richard Mavrinac, formerly the CFO of George Weston Limited and Executive Vice President of Loblaw Companies Limited, two of Canada’s largest companies operating in the retail grocery and bakery sectors, will be joining Gage Cannabis’ board to assist the company on its future growth strategy. Mr. Mavrinac is also a member of the Board of Directors of TerrAscend Corp., Roots Corporation and Canopy Rivers Inc., and will bring a significant wealth of experience within the retail and cannabis sector to Gage Cannabis executive team. For more information, visit the company’s website at www.GageUSA.com. NOTE TO INVESTORS: The latest news and updates relating to Gage Cannabis are available in the company’s newsroom at https://ibn.fm/GAGE